Neurological disorders

Disorders of the nervous system.

Key developments include ultragenyx's angelman syndrome drug fails phase 3 trial, kyverna therapeutics plans fda submission for stiff person syndrome cell therapy, novartis pauses autoimmune cell therapy trials after three patient deaths, among other significant events and policy changes.

Source: Geo Health Space